{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:39:13Z","timestamp":1794944353738,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008798","name":"Ministry of Science Research and Technology","doi-asserted-by":"crossref","award":["700\/12"],"award-info":[{"award-number":["700\/12"]}],"id":[{"id":"10.13039\/501100008798","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005756","name":"shahrekord university of medical sciences","doi-asserted-by":"publisher","award":["2763 and 1737"],"award-info":[{"award-number":["2763 and 1737"]}],"id":[{"id":"10.13039\/501100005756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Critical inter-provincial differences within Iran in the pattern of non-communicable diseases (NCDs) and difficulties inherent to identifying prevention methods to reduce mortality from NCDs have challenged the implementation of the provincial health system plan. The Shahrekord Cohort Study (SCS) was designed to address these gaps in Chaharmahal and Bakhtiari, a province of high altitude in the southwest of Iran, characterized by its large Bakhtiari population, along with Fars and Turk ethnicity groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This ongoing cohort, a prospective, large-scale longitudinal study, includes a unique, rich biobank and was conducted for the first time in Chaharmahal and Bakhtiari Province in Iran. SCS is a part of the PERSIAN (Prospective Epidemiological Research Studies in IrAN) cohort. The study began in 2015, recruited 10075 participants (52.8% female, 47.2% male) from both urban (n=7034) and rural (<jats:italic>n<\/jats:italic>=3041) areas, and participants will be annually followed up for at least 15 years. A cross-sectional analysis was conducted using baseline data from the SCS, using descriptive statistics and logistic regression. Data analysis was performed using Stata software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of NCDs was 9.8% for type 2 diabetes, 17.1% for hypertension, 11.6% for thyroid disease, 0.2% for multiple sclerosis and 5.7, 0.9 and 1.3% for ischemic heart disease, stroke and myocardial infarction, respectively. The prevalence of multimorbidity (\u22652 NCDs) was higher in women (39.1%) than men (24.9%). The means (standard deviations) of age, BMI, systolic blood pressure and fasting blood glucose were 49.5 (9) years, 27.6 (4.6) kg\/m<jats:sup>2<\/jats:sup>, 115.4 (17.3) mmHg and 96.7 (27.3) mg\/dL, respectively. Logistic regression models showed that older age, female gender, living in an urban area, non-native ethnicity, high wealth index, unemployment, obesity, low physical activity, hypertriglyceridemia, high fasting blood sugar, alkaline urine pH and high systolic and diastolic blood pressure were associated with increased prevalence of NCDs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The SCS provides a platform for epidemiological studies that will be useful to better control NCDs in the southwest of Iran and to foster research collaboration. The SCS will be an essential resource for identifying NCD risk factors in this region and designing relevant public health interventions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-12326-y","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T15:03:52Z","timestamp":1639407832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1588-2136","authenticated-orcid":false,"given":"Ali","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Shirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsalan","family":"Khaledifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Hashemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Solati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soleiman","family":"Kheiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehraban","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdollah","family":"Mohammadian-Hafshejani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi Raeisi","family":"Shahraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Asgharzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Zamen","family":"Salehifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Zarean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Goujani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Saeed Hashemi","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Poustchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Antoine","family":"Dugu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"12326_CR1","unstructured":"World Health Organization. Non-communicable diseases and mental health, Global Action Plan for the Prevention and Control of NCDs 2013-2020. https:\/\/www.who.int\/nmh\/events\/ncd_action_plan\/en\/. Accessed 5 Mar, 2020."},{"issue":"12","key":"12326_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"Global Burden of Disease Cancer Collaboration","year":"2019","unstructured":"Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2019;5(12):1749\u201368.","journal-title":"JAMA Oncol"},{"issue":"1","key":"12326_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12889-020-8446-x","volume":"20","author":"A Bakhtiari","year":"2020","unstructured":"Bakhtiari A, Takian A, Majdzadeh R, Haghdoost AA. Assessment and prioritization of the WHO \u201cbest buys\u201d and other recommended interventions for the prevention and control of non-communicable diseases in Iran. BMC Public Health. 2020;20(1):333.","journal-title":"BMC Public Health"},{"issue":"9","key":"12326_CR4","first-page":"608","volume":"20","author":"S Djalalinia","year":"2017","unstructured":"Djalalinia S, Modirian M, Sheidaei A, et al. Protocol design for large\u2013scale cross-sectional studies of surveillance of risk factors of non\u2013communicable diseases in Iran: STEPs 2016. Arch Iran Med. 2017;20(9):608\u201316.","journal-title":"Arch Iran Med"},{"issue":"1","key":"12326_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40200-017-0288-4","volume":"16","author":"N Peykari","year":"2017","unstructured":"Peykari N, Hashemi H, Dinarvand R, et al. National action plan for non-communicable disease prevention and control in Iran; a response to the emerging epidemic. J Diabetes Metab Disord. 2017;16(1):3.","journal-title":"J Diabetes Metab Disord"},{"issue":"6","key":"12326_CR6","first-page":"511","volume":"19","author":"A Alwan","year":"2013","unstructured":"Alwan A. The World Health Assembly responds to the global challenge of non-communicable diseases. East Mediterr Health J. 2013;19(6):511\u20132.","journal-title":"East Mediterr Health J"},{"issue":"10184","key":"12326_CR7","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0140-6736(18)33197-0","volume":"393","author":"G Danaei","year":"2019","unstructured":"Danaei G, Farzadfar F, Kelishadi R, et al. Iran in transition. Lancet. 2019;393(10184):1984\u20132005.","journal-title":"Lancet."},{"key":"12326_CR8","volume-title":"Non-communicable diseases progress monitor","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Non-communicable diseases progress monitor 2020 https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/330805\/9789240000490-eng.pdf Accessed 3 Jun 2021."},{"issue":"1","key":"12326_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/ije\/dyp161","volume":"39","author":"A Pourshams","year":"2010","unstructured":"Pourshams A, Khademi H, Malekshah AF, et al. Cohort profile: The Golestan Cohort Study-a prospective study of oesophageal cancer in Northern Iran. Int J Epidemiol. 2010;39(1):52\u20139.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"12326_CR10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/ije\/dyt089","volume":"43","author":"SR Hosseini","year":"2014","unstructured":"Hosseini SR, Cumming RG, Kheirkhah F, et al. Cohort profile: The Amirkola Health and Ageing Project (AHAP). Int J Epidemiol. 2014;43(5):1393\u2013400.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"12326_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/ije\/dyx231","volume":"47","author":"M Mirzaei","year":"2018","unstructured":"Mirzaei M, Salehi-Abargouei A, Mirzaei M, Mohsenpour MA. Cohort Profile: The Yazd Health Study (YaHS): a population-based study of adults aged 20\u201370 years (study design and baseline population data). Int J Epidemiol. 2018;47(3):697\u20138.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"12326_CR12","first-page":"84777","volume":"16","author":"F Azizi","year":"2018","unstructured":"Azizi F, Zadeh-Vakili A, Takyar M. Review of rationale, design, and initial findings: Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018;16(4):84777.","journal-title":"Int J Endocrinol Metab"},{"issue":"4","key":"12326_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi H, Eghtesad S, Kamangar F, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647\u201355.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"12326_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/ije\/dyy296","volume":"48","author":"Y Pasdar","year":"2019","unstructured":"Pasdar Y, Najafi F, Moradinazar M, et al. Cohort profile: Ravansar non-communicable disease cohort study: the first cohort study in a Kurdish population. Int J Epidemiol. 2019;48(3):682\u20133.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"12326_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/ije\/dyy215","volume":"48","author":"S Farhang","year":"2019","unstructured":"Farhang S, Faramarzi E, Amini Sani N, et al. Cohort profile: The AZAR cohort, a health-oriented research model in areas of major environmental change in Central Asia. Int J Epidemiol. 2019;48(2):382.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"12326_CR16","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1186\/s12889-016-3760-z","volume":"16","author":"M Farjam","year":"2016","unstructured":"Farjam M, Bahrami H, Bahramali E, et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa cohort study. BMC Public Health. 2016;16(1):1090.","journal-title":"BMC Public Health"},{"issue":"6","key":"12326_CR17","first-page":"279","volume":"22","author":"M Kheradmand","year":"2019","unstructured":"Kheradmand M, Moosazadeh M, Saeedi M, et al. Tabari cohort profile and preliminary results in urban areas and mountainous regions of Mazandaran, Iran. Arch Iran Med. 2019;22(6):279\u201385.","journal-title":"Arch Iran Med"},{"issue":"1","key":"12326_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12889-018-5364-2","volume":"18","author":"A Khaledifar","year":"2018","unstructured":"Khaledifar A, Hashemzadeh M, Solati K, et al. The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study. BMC Public Health. 2018;18(1):660.","journal-title":"BMC Public Health"},{"issue":"3","key":"12326_CR19","first-page":"106","volume":"3","author":"S Farjadian","year":"2006","unstructured":"Farjadian S, Ghaderi A. Iranian lurs genetic diversity: an anthropological view based on HLA class II profiles. Iran J Immunol. 2006;3(3):106\u201313.","journal-title":"Iran J Immunol"},{"issue":"5-6","key":"12326_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000355140","volume":"70","author":"M Etemadifar","year":"2013","unstructured":"Etemadifar M, Sajjadi S, Nasr Z, et al. Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol. 2013;70(5-6):356\u201363.","journal-title":"Eur Neurol"},{"issue":"1","key":"12326_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12903-020-1036-6","volume":"20","author":"M Soofi","year":"2020","unstructured":"Soofi M, Pasdar Y, Karami Matin B, et al. Socioeconomic-related inequalities in oral hygiene behaviors: a cross-sectional analysis of the PERSIAN cohort study. BMC Oral Health. 2020;20(1):63.","journal-title":"BMC Oral Health"},{"issue":"1","key":"12326_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1477-7525-1-66","volume":"1","author":"A Montazeri","year":"2003","unstructured":"Montazeri A, Harirchi AM, Shariati M, Garmaroudi G, Ebadi M, Fateh A. The 12-item General Health Questionnaire (GHQ-12): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003;1(1):66.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"12326_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15171\/ijer.2019.32","volume":"6","author":"F Salehi","year":"2019","unstructured":"Salehi F, Ahmadi A. The investigation of psychometric properties (validity and reliability reassessment) of WHO QOL-BREF Questionnaire in Shahrekord Cohort Study. Int J Epidemiol Res. 2019;6(4):182\u20137.","journal-title":"Int J Epidemiol Res"},{"issue":"3","key":"12326_CR24","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.dsx.2019.05.006","volume":"13","author":"A Ahmadi","year":"2019","unstructured":"Ahmadi A, Sodejani SA, Malekzadeh R, Poustchi H, Solati K. Study of correlation between chronic stressor, biochemical markers and hematologic indices in Shahrekord Cohort Study: A population-based cross-sectional study. Diabetes Metab Syndr. 2019;13(3):2170\u20134.","journal-title":"Diabetes Metab Syndr"},{"issue":"11","key":"12326_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41371-018-0126-2","volume":"33","author":"N Sarrafzadegan","year":"2019","unstructured":"Sarrafzadegan N, Hassannejad R, Roohafza H, et al. A 10-year Isfahan cohort on cardiovascular disease as a master plan for a multi-generation non-communicable disease longitudinal study: methodology and challenges. J Hum Hypertens. 2019;33(11):807\u201316.","journal-title":"J Hum Hypertens"},{"key":"12326_CR26","first-page":"17","volume":"28","author":"A Yari","year":"2014","unstructured":"Yari A, Nadrian H, Rashidian H, et al. Psychometric properties of the Persian version of Social Capital Questionnaire in Iran. Med J Islam Repub Iran. 2014;28:17.","journal-title":"Med J Islam Repub Iran"},{"issue":"11","key":"12326_CR27","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/1756-185X.12809","volume":"19","author":"F Davatchi","year":"2016","unstructured":"Davatchi F, Sandoughi M, Moghimi N, et al. Epidemiology of rheumatic diseases in Iran from analysis of four COPCORD studies. Int J Rheum Dis. 2016;19(11):1056\u201362.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"12326_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.29252\/jhehp.5.1.5","volume":"5","author":"A Ahmadi","year":"2019","unstructured":"Ahmadi A, Salehi F. Construct validation of the health literacy questionnaire (HLQ) in Shahrekord Cohort Study, Iran. J Hum Environ Health Promot. 2019;5(1):26\u201331.","journal-title":"J Hum Environ Health Promot"},{"issue":"3","key":"12326_CR29","first-page":"326","volume":"46","author":"M Malmir","year":"2017","unstructured":"Malmir M, Khanahmadi M, Farhud D. Dogmatism and happiness. Iran J Public Health. 2017;46(3):326\u201332.","journal-title":"Iran J Public Health"},{"issue":"2","key":"12326_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4184\/asj.2016.10.2.215","volume":"10","author":"A Baradaran","year":"2016","unstructured":"Baradaran A, Ebrahimzadeh MH, Birjandinejad A, Kachooei AR. Cross-cultural adaptation, validation, and reliability testing of the modified Oswestry Disability Questionnaire in Persian population with low back pain. Asian Spine J. 2016;10(2):215\u20139.","journal-title":"Asian Spine J"},{"issue":"1","key":"12326_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12890-021-01469-8","volume":"21","author":"FZ Kiani","year":"2021","unstructured":"Kiani FZ, Ahmadi A, Babadi AS, Rouhi H. Profile and preliminary results of Iranian sub cohort chronic obstructive pulmonary disease (COPD) in Shahrekord PERSIAN cohort in southwest Iran. BMC Pulm Med. 2021;21(1):105.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"12326_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10654-020-00668-7","volume":"36","author":"H Hakimi","year":"2021","unstructured":"Hakimi H, Ahmadi J, Vakilian A, et al. The profile of Rafsanjan Cohort Study. Eur J Epidemiol. 2021;36(2):243\u201352.","journal-title":"Eur J Epidemiol"},{"key":"12326_CR33","first-page":"141","volume":"34","author":"B Cheraghian","year":"2020","unstructured":"Cheraghian B, Hashemi SJ, Hosseini SA, et al. Cohort profile: The Hoveyzeh Cohort Study (HCS): a prospective population-based study on non-communicable diseases in an Arab community of Southwest Iran. Med J Islam Repub Iran. 2020;34:141.","journal-title":"Med J Islam Repub Iran"},{"issue":"1","key":"12326_CR34","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1186\/s12889-020-09214-2","volume":"20","author":"N Aminisani","year":"2020","unstructured":"Aminisani N, Rastgou L, Shamshirgaran SM, Sarbakhsh P, Ghaderi S, Hyde M. Predictors of multimorbidity among the Kurdish population living in the Northwest of Iran. BMC Public Health. 2020;20(1):1094.","journal-title":"BMC Public Health"},{"issue":"7","key":"12326_CR35","doi-asserted-by":"publisher","first-page":"e2756","DOI":"10.1097\/MD.0000000000002756","volume":"95","author":"B Ahmadi","year":"2016","unstructured":"Ahmadi B, Alimohammadian M, Yaseri M, Majidi A, Boreiri M, Islami F, et al. Multimorbidity: epidemiology and risk factors in the Golestan cohort study, Iran: a cross-sectional analysis. Medicine. 2016;95(7):e2756.","journal-title":"Medicine."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-12326-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-12326-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-12326-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T15:04:56Z","timestamp":1639407896000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-12326-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["12326"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-12326-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"12 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the guidelines of the Declaration of Helsinki and the National Ethical Guidelines in Biomedical Research in Iran. The study was approved by the Ethics Committee of the Shahrekord University of Medical Sciences (SKUMS) (IR.SKUMS.REC.1394.286) at regional and national scales. All participants provided signed and fingerprinted informed written consent, as per the SKUMS Ethics Committee guidelines. For illiterate participants, the informed consent form was read. After authorization, the consent form was fingerprinted and signed and confirmed by their first-degree family member or legally authorized representatives. The participants can withdraw from the study whenever they wish. Data are stored in an anonymized and protected confidential database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2275"}}